Bioelectric neuromodulation for gastrointestinal disorders: effectiveness and mechanisms
| dc.contributor.author | Payne, Sophie | |
| dc.contributor.author | Furness, John | |
| dc.contributor.author | Stebbing, Martin | |
| dc.date.accessioned | 2019-05-06T04:25:45Z | |
| dc.date.available | 2019-05-06T04:25:45Z | |
| dc.date.issued | 2018-05 | |
| dc.description.abstract | The gastrointestinal tract has extensive, surgically accessible nerve connections with the central nervous system. This provides the opportunity to exploit rapidly advancing methods of nerve stimulation to treat gastrointestinal disorders. Bioelectric neuromodulation technology has considerably advanced in the past decade, but sacral nerve stimulation for faecal incontinence currently remains the only neuromodulation protocol in general use for a gastrointestinal disorder. Treatment of other conditions, such as IBD, obesity, nausea and gastroparesis, has had variable success. That nerves modulate inflammation in the intestine is well established, but the anti-inflammatory effects of vagal nerve stimulation have only recently been discovered, and positive effects of this approach were seen in only some patients with Crohn's disease in a single trial. Pulses of high-frequency current applied to the vagus nerve have been used to block signalling from the stomach to the brain to reduce appetite with variable outcomes. Bioelectric neuromodulation has also been investigated for postoperative ileus, gastroparesis symptoms and constipation in animal models and some clinical trials. The clinical success of this bioelectric neuromodulation therapy might be enhanced through better knowledge of the targeted nerve pathways and their physiological and pathophysiological roles, optimizing stimulation protocols and determining which patients benefit most from this therapy. | en_US |
| dc.description.sponsorship | Work on bioelectric modulation for inflammatory bowel disease is supported by the Defense Advanced Research Projects Agency (DARPA) BTO through the Space and Naval Warfare Systems Center Contract No. N66001-15-2-4060 to J.B.F., and work on gastric disorders by NIH (SPARC) grant ID# OT2OD023847 to J.B.F., the National Institutes of Health (NIH) and the National Health and Medical Research Council of Australia. | en_US |
| dc.identifier.citation | Payne, S. C., J. B. Furness, and M. J. Stebbing. 2018. Bioelectric neuromodulation for gastrointestinal disorders: effectiveness and mechanisms. Nature reviews. Gastroenterology & hepatology. 16(2): 89-105. | en_US |
| dc.identifier.issn | 1759-5045 | |
| dc.identifier.uri | http://repository.bionicsinstitute.org:8080/handle/123456789/350 | |
| dc.language.iso | en | en_US |
| dc.publisher | Nature Reviews | en_US |
| dc.title | Bioelectric neuromodulation for gastrointestinal disorders: effectiveness and mechanisms | en_US |
| dc.type | Article | en_US |